Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

The article concludes that the global hair trade is exploitative and reflects complex cultural and economic issues.

Body and beard hair can be used for hair restoration in severely bald patients, but the technique is complex and costly.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Minoxidil improves quality of life for women with hair loss.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Alternative medicine lacks scientific support and relies on the placebo effect, but remains popular and integrated into German healthcare.

The document suggests that certain protein deficiencies and scalp blistering in Epidermolysis Bullosa may cause hair loss.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Hair loss from cancer treatment is very distressing for women due to its impact on self-image and social stigma.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Fiber implantation for baldness is not recommended because it causes many problems and doesn't work well.

The article concludes that microvascular free flaps, especially the latissimus dorsi flap, are recommended for large scalp reconstructions, and hair transplantation offers high survival rates and excellent aesthetic results.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

The review concluded that male pattern baldness is mostly seen negatively, affecting attractiveness and social appeal.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.